(Q28368207)

1

0 references

Y Ohmura

2

0 references

K Suzuki

3

0 references

N Ono

4

0 references

H Nakazawa

5

0 references

M Aoki

6

0 references

I Tanabe

7

0 references

T Sekiyama

8

0 references

T Tsuji

9

0 references

M Okunishi

10

0 references

K Yamanishi

11

0 references

Y Nishiyama

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animals

12

0 references

language of work or name

English

0 references

publication date

June 1999

0 references

published in

Antiviral Research

0 references

volume

42

0 references

issue

2

0 references

page(s)

139-48

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021

Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900024-8

7 January 2021